Johnson & Johnson

Johnson & Johnson’s standalone nasal spray for depression gets FDA nod

The United States Food and Drug Administration (FDA) has approved Spravato, a nasal spray by Johnson & Johnson as a stand-alone treatment for adults with Major Depressive Disorder (MDD).  The spray is…